Source: www.marketwire.com --- Friday, March 23, 2012
ALISO VIEJO, CA (MARKET WIRE) CNS Response, Inc. (OTCBB: CNSO) today announced that the U.S. Food and Drug Administration (FDA) responded to its proposal for a clinical trial of an Investigational Device, PEER Interactive, designed to support physicians in identifying the best treatments for certain mental illnesses. In response to the comments provided by the FDA, CNS Response intends to revise the protocol and launch a clinical trial with Walter Reed National Military Medical Center (WRNMMC) and several other sites, partnering with Military physicians treating 2,000 patients diagnosed with mental health conditions such ...
Source: http://pb.marketwire.com/PersonalBeatWeb/rld?encsuid=25940C8E045F5EFE&suid=2374087&prid=865910&src=3
fsu football fsu football do a barrelroll bérénice marlohe bérénice marlohe google offers cerebral palsy
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.